GlassScriptPhysician profile
Tapash K Palit
NPI 1801004262
$3,311.57
in general payments reported to CMS, 2019-2025
10 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2021: $19.61 · 2022: $527 · 2023: $553 · 2024: $761 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,829.51 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Propaten Vascular Graft |
| Silk Road Medical, INC. | $797.00 | 2019-2022 | |
| Truvic Medical, INC. | $195.80 | 2022 | |
| Imperative Care, INC | $135.02 | 2023-2025 | Symphony Catheter, Prodigy Catheter |
| Bolton Medical INC | $123.74 | 2019 | |
| Siemens Medical Solutions USA, INC. | $96.49 | 2025 | Artis Icono Biplane |
| Lemaitre Vascular, INC. | $42.49 | 2025 | Eze-Sit Valvulotome |
| Boston Scientific Corporation | $35.38 | 2025 | Enroute Transcarotid Neuroprotection System |
| Janssen Pharmaceuticals, INC | $32.02 | 2021-2022 | |
| Inari Medical, INC. | $24.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tapash Palit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.